Discover how Geneo, Singapore's new life sciences hub, is bridging companies with talent and fostering vital collaboration ...
Johnson & Johnson is rated Hold, trading near intrinsic value with limited upside based on a 20x multiple and $12 normalized EPS. Q1 results showed 10% sales growth and a $450M revenue beat, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results